Janet Dorling
Chief Commercial Officer, Achaogen, Inc.
Companies
- CymaBay Therapeutics (United States)Board member Apr 5, 2021 to Mar 22, 20241
- CymaBay Therapeutics (United States)Chief Commercial Officer Aug 5, 2019 to Aug 5, 20192
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CymaBay Therapeutics (United States)0 shares3Feb 12, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 12, 2024Sold 6,000 shares at $31.97 of CymaBay Therapeutics (United States)3
- Feb 12, 2024Exercised options 6,000 shares at $4.63 of CymaBay Therapeutics (United States)3
- Jan 10, 2024Sold 6,000 shares at $23.86 of CymaBay Therapeutics (United States)4
- Jan 10, 2024Exercised options 6,000 shares at $4.63 of CymaBay Therapeutics (United States)4
- Dec 11, 2023Sold 6,000 shares at $20.07 of CymaBay Therapeutics (United States)5
- Dec 11, 2023Exercised options 6,000 shares at $4.63 of CymaBay Therapeutics (United States)5
- Nov 10, 2023Sold 7,000 shares at $15.24 of CymaBay Therapeutics (United States)6
- Nov 10, 2023Exercised options 7,000 shares at $4.63 of CymaBay Therapeutics (United States)6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 10, 2024
- 5SEC EDGARForm 4 filed Dec 11, 2023
- 6SEC EDGARForm 4 filed Nov 14, 2023